Global Gastrointestinal Disorder Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview
Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases.
This report provides a deep insight into the global Gastrointestinal Disorder Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Disorder Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Disorder Therapeutics market in any manner.
Global Gastrointestinal Disorder Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca
Takeda Pharmaceutical
Johnson & Johnson
Eisai
Abbott Laboratories
Salix Pharmaceuticals
Bausch Health
Allergan
Bayer
UCB
AbbVie
GlaxoSmithKline
Astellas Pharma
Market Segmentation (by Type)
Irritable Bowel Syndrome (IBS)
Chronic Constipation (CC)
Ulcerative Colitis (UC)
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Disorder Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases.
This report provides a deep insight into the global Gastrointestinal Disorder Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Disorder Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Disorder Therapeutics market in any manner.
Global Gastrointestinal Disorder Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca
Takeda Pharmaceutical
Johnson & Johnson
Eisai
Abbott Laboratories
Salix Pharmaceuticals
Bausch Health
Allergan
Bayer
UCB
AbbVie
GlaxoSmithKline
Astellas Pharma
Market Segmentation (by Type)
Irritable Bowel Syndrome (IBS)
Chronic Constipation (CC)
Ulcerative Colitis (UC)
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gastrointestinal Disorder Therapeutics Market
- Overview of the regional outlook of the Gastrointestinal Disorder Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Disorder Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gastrointestinal Disorder Therapeutics
1.2 Key Market Segments
1.2.1 Gastrointestinal Disorder Therapeutics Segment by Type
1.2.2 Gastrointestinal Disorder Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Disorder Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastrointestinal Disorder Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Gastrointestinal Disorder Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal Disorder Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastrointestinal Disorder Therapeutics Sales Sites, Area Served, Product Type
3.6 Gastrointestinal Disorder Therapeutics Market Competitive Situation and Trends
3.6.1 Gastrointestinal Disorder Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastrointestinal Disorder Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL DISORDER THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Disorder Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL DISORDER THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Disorder Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Gastrointestinal Disorder Therapeutics Price by Type (2019-2024)
7 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Disorder Therapeutics Market Sales by Application (2019-2024)
7.3 Global Gastrointestinal Disorder Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Gastrointestinal Disorder Therapeutics Sales Growth Rate by Application (2019-2024)
8 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Gastrointestinal Disorder Therapeutics Sales by Region
8.1.1 Global Gastrointestinal Disorder Therapeutics Sales by Region
8.1.2 Global Gastrointestinal Disorder Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Gastrointestinal Disorder Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastrointestinal Disorder Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastrointestinal Disorder Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastrointestinal Disorder Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastrointestinal Disorder Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AstraZeneca
9.1.1 AstraZeneca Gastrointestinal Disorder Therapeutics Basic Information
9.1.2 AstraZeneca Gastrointestinal Disorder Therapeutics Product Overview
9.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Product Market Performance
9.1.4 AstraZeneca Business Overview
9.1.5 AstraZeneca Gastrointestinal Disorder Therapeutics SWOT Analysis
9.1.6 AstraZeneca Recent Developments
9.2 Takeda Pharmaceutical
9.2.1 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Basic Information
9.2.2 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Overview
9.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Market Performance
9.2.4 Takeda Pharmaceutical Business Overview
9.2.5 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics SWOT Analysis
9.2.6 Takeda Pharmaceutical Recent Developments
9.3 Johnson and Johnson
9.3.1 Johnson and Johnson Gastrointestinal Disorder Therapeutics Basic Information
9.3.2 Johnson and Johnson Gastrointestinal Disorder Therapeutics Product Overview
9.3.3 Johnson and Johnson Gastrointestinal Disorder Therapeutics Product Market Performance
9.3.4 Johnson and Johnson Gastrointestinal Disorder Therapeutics SWOT Analysis
9.3.5 Johnson and Johnson Business Overview
9.3.6 Johnson and Johnson Recent Developments
9.4 Eisai
9.4.1 Eisai Gastrointestinal Disorder Therapeutics Basic Information
9.4.2 Eisai Gastrointestinal Disorder Therapeutics Product Overview
9.4.3 Eisai Gastrointestinal Disorder Therapeutics Product Market Performance
9.4.4 Eisai Business Overview
9.4.5 Eisai Recent Developments
9.5 Abbott Laboratories
9.5.1 Abbott Laboratories Gastrointestinal Disorder Therapeutics Basic Information
9.5.2 Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Overview
9.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Market Performance
9.5.4 Abbott Laboratories Business Overview
9.5.5 Abbott Laboratories Recent Developments
9.6 Salix Pharmaceuticals
9.6.1 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Basic Information
9.6.2 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Overview
9.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Market Performance
9.6.4 Salix Pharmaceuticals Business Overview
9.6.5 Salix Pharmaceuticals Recent Developments
9.7 Bausch Health
9.7.1 Bausch Health Gastrointestinal Disorder Therapeutics Basic Information
9.7.2 Bausch Health Gastrointestinal Disorder Therapeutics Product Overview
9.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Product Market Performance
9.7.4 Bausch Health Business Overview
9.7.5 Bausch Health Recent Developments
9.8 Allergan
9.8.1 Allergan Gastrointestinal Disorder Therapeutics Basic Information
9.8.2 Allergan Gastrointestinal Disorder Therapeutics Product Overview
9.8.3 Allergan Gastrointestinal Disorder Therapeutics Product Market Performance
9.8.4 Allergan Business Overview
9.8.5 Allergan Recent Developments
9.9 Bayer
9.9.1 Bayer Gastrointestinal Disorder Therapeutics Basic Information
9.9.2 Bayer Gastrointestinal Disorder Therapeutics Product Overview
9.9.3 Bayer Gastrointestinal Disorder Therapeutics Product Market Performance
9.9.4 Bayer Business Overview
9.9.5 Bayer Recent Developments
9.10 UCB
9.10.1 UCB Gastrointestinal Disorder Therapeutics Basic Information
9.10.2 UCB Gastrointestinal Disorder Therapeutics Product Overview
9.10.3 UCB Gastrointestinal Disorder Therapeutics Product Market Performance
9.10.4 UCB Business Overview
9.10.5 UCB Recent Developments
9.11 AbbVie
9.11.1 AbbVie Gastrointestinal Disorder Therapeutics Basic Information
9.11.2 AbbVie Gastrointestinal Disorder Therapeutics Product Overview
9.11.3 AbbVie Gastrointestinal Disorder Therapeutics Product Market Performance
9.11.4 AbbVie Business Overview
9.11.5 AbbVie Recent Developments
9.12 GlaxoSmithKline
9.12.1 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Basic Information
9.12.2 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Overview
9.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Market Performance
9.12.4 GlaxoSmithKline Business Overview
9.12.5 GlaxoSmithKline Recent Developments
9.13 Astellas Pharma
9.13.1 Astellas Pharma Gastrointestinal Disorder Therapeutics Basic Information
9.13.2 Astellas Pharma Gastrointestinal Disorder Therapeutics Product Overview
9.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Product Market Performance
9.13.4 Astellas Pharma Business Overview
9.13.5 Astellas Pharma Recent Developments
10 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Gastrointestinal Disorder Therapeutics Market Size Forecast
10.2 Global Gastrointestinal Disorder Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastrointestinal Disorder Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Gastrointestinal Disorder Therapeutics Market Size Forecast by Region
10.2.4 South America Gastrointestinal Disorder Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal Disorder Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gastrointestinal Disorder Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastrointestinal Disorder Therapeutics by Type (2025-2030)
11.1.2 Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastrointestinal Disorder Therapeutics by Type (2025-2030)
11.2 Global Gastrointestinal Disorder Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Gastrointestinal Disorder Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Gastrointestinal Disorder Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gastrointestinal Disorder Therapeutics
1.2 Key Market Segments
1.2.1 Gastrointestinal Disorder Therapeutics Segment by Type
1.2.2 Gastrointestinal Disorder Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Disorder Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastrointestinal Disorder Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Gastrointestinal Disorder Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal Disorder Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastrointestinal Disorder Therapeutics Sales Sites, Area Served, Product Type
3.6 Gastrointestinal Disorder Therapeutics Market Competitive Situation and Trends
3.6.1 Gastrointestinal Disorder Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastrointestinal Disorder Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL DISORDER THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Disorder Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL DISORDER THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Disorder Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Gastrointestinal Disorder Therapeutics Price by Type (2019-2024)
7 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Disorder Therapeutics Market Sales by Application (2019-2024)
7.3 Global Gastrointestinal Disorder Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Gastrointestinal Disorder Therapeutics Sales Growth Rate by Application (2019-2024)
8 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Gastrointestinal Disorder Therapeutics Sales by Region
8.1.1 Global Gastrointestinal Disorder Therapeutics Sales by Region
8.1.2 Global Gastrointestinal Disorder Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Gastrointestinal Disorder Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastrointestinal Disorder Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastrointestinal Disorder Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastrointestinal Disorder Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastrointestinal Disorder Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AstraZeneca
9.1.1 AstraZeneca Gastrointestinal Disorder Therapeutics Basic Information
9.1.2 AstraZeneca Gastrointestinal Disorder Therapeutics Product Overview
9.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Product Market Performance
9.1.4 AstraZeneca Business Overview
9.1.5 AstraZeneca Gastrointestinal Disorder Therapeutics SWOT Analysis
9.1.6 AstraZeneca Recent Developments
9.2 Takeda Pharmaceutical
9.2.1 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Basic Information
9.2.2 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Overview
9.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Market Performance
9.2.4 Takeda Pharmaceutical Business Overview
9.2.5 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics SWOT Analysis
9.2.6 Takeda Pharmaceutical Recent Developments
9.3 Johnson and Johnson
9.3.1 Johnson and Johnson Gastrointestinal Disorder Therapeutics Basic Information
9.3.2 Johnson and Johnson Gastrointestinal Disorder Therapeutics Product Overview
9.3.3 Johnson and Johnson Gastrointestinal Disorder Therapeutics Product Market Performance
9.3.4 Johnson and Johnson Gastrointestinal Disorder Therapeutics SWOT Analysis
9.3.5 Johnson and Johnson Business Overview
9.3.6 Johnson and Johnson Recent Developments
9.4 Eisai
9.4.1 Eisai Gastrointestinal Disorder Therapeutics Basic Information
9.4.2 Eisai Gastrointestinal Disorder Therapeutics Product Overview
9.4.3 Eisai Gastrointestinal Disorder Therapeutics Product Market Performance
9.4.4 Eisai Business Overview
9.4.5 Eisai Recent Developments
9.5 Abbott Laboratories
9.5.1 Abbott Laboratories Gastrointestinal Disorder Therapeutics Basic Information
9.5.2 Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Overview
9.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Market Performance
9.5.4 Abbott Laboratories Business Overview
9.5.5 Abbott Laboratories Recent Developments
9.6 Salix Pharmaceuticals
9.6.1 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Basic Information
9.6.2 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Overview
9.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Market Performance
9.6.4 Salix Pharmaceuticals Business Overview
9.6.5 Salix Pharmaceuticals Recent Developments
9.7 Bausch Health
9.7.1 Bausch Health Gastrointestinal Disorder Therapeutics Basic Information
9.7.2 Bausch Health Gastrointestinal Disorder Therapeutics Product Overview
9.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Product Market Performance
9.7.4 Bausch Health Business Overview
9.7.5 Bausch Health Recent Developments
9.8 Allergan
9.8.1 Allergan Gastrointestinal Disorder Therapeutics Basic Information
9.8.2 Allergan Gastrointestinal Disorder Therapeutics Product Overview
9.8.3 Allergan Gastrointestinal Disorder Therapeutics Product Market Performance
9.8.4 Allergan Business Overview
9.8.5 Allergan Recent Developments
9.9 Bayer
9.9.1 Bayer Gastrointestinal Disorder Therapeutics Basic Information
9.9.2 Bayer Gastrointestinal Disorder Therapeutics Product Overview
9.9.3 Bayer Gastrointestinal Disorder Therapeutics Product Market Performance
9.9.4 Bayer Business Overview
9.9.5 Bayer Recent Developments
9.10 UCB
9.10.1 UCB Gastrointestinal Disorder Therapeutics Basic Information
9.10.2 UCB Gastrointestinal Disorder Therapeutics Product Overview
9.10.3 UCB Gastrointestinal Disorder Therapeutics Product Market Performance
9.10.4 UCB Business Overview
9.10.5 UCB Recent Developments
9.11 AbbVie
9.11.1 AbbVie Gastrointestinal Disorder Therapeutics Basic Information
9.11.2 AbbVie Gastrointestinal Disorder Therapeutics Product Overview
9.11.3 AbbVie Gastrointestinal Disorder Therapeutics Product Market Performance
9.11.4 AbbVie Business Overview
9.11.5 AbbVie Recent Developments
9.12 GlaxoSmithKline
9.12.1 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Basic Information
9.12.2 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Overview
9.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Market Performance
9.12.4 GlaxoSmithKline Business Overview
9.12.5 GlaxoSmithKline Recent Developments
9.13 Astellas Pharma
9.13.1 Astellas Pharma Gastrointestinal Disorder Therapeutics Basic Information
9.13.2 Astellas Pharma Gastrointestinal Disorder Therapeutics Product Overview
9.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Product Market Performance
9.13.4 Astellas Pharma Business Overview
9.13.5 Astellas Pharma Recent Developments
10 GASTROINTESTINAL DISORDER THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Gastrointestinal Disorder Therapeutics Market Size Forecast
10.2 Global Gastrointestinal Disorder Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastrointestinal Disorder Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Gastrointestinal Disorder Therapeutics Market Size Forecast by Region
10.2.4 South America Gastrointestinal Disorder Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal Disorder Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gastrointestinal Disorder Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastrointestinal Disorder Therapeutics by Type (2025-2030)
11.1.2 Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastrointestinal Disorder Therapeutics by Type (2025-2030)
11.2 Global Gastrointestinal Disorder Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Gastrointestinal Disorder Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Gastrointestinal Disorder Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Disorder Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Disorder Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastrointestinal Disorder Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastrointestinal Disorder Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2022)
Table 10. Global Market Gastrointestinal Disorder Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastrointestinal Disorder Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal Disorder Therapeutics Product Type
Table 13. Global Gastrointestinal Disorder Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal Disorder Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Disorder Therapeutics Market Challenges
Table 22. Global Gastrointestinal Disorder Therapeutics Sales by Type (K Units)
Table 23. Global Gastrointestinal Disorder Therapeutics Market Size by Type (M USD)
Table 24. Global Gastrointestinal Disorder Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Gastrointestinal Disorder Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastrointestinal Disorder Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Gastrointestinal Disorder Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gastrointestinal Disorder Therapeutics Sales (K Units) by Application
Table 30. Global Gastrointestinal Disorder Therapeutics Market Size by Application
Table 31. Global Gastrointestinal Disorder Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Gastrointestinal Disorder Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastrointestinal Disorder Therapeutics Market Share by Application (2019-2024)
Table 35. Global Gastrointestinal Disorder Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastrointestinal Disorder Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Gastrointestinal Disorder Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gastrointestinal Disorder Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gastrointestinal Disorder Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Gastrointestinal Disorder Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gastrointestinal Disorder Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca Gastrointestinal Disorder Therapeutics Basic Information
Table 44. AstraZeneca Gastrointestinal Disorder Therapeutics Product Overview
Table 45. AstraZeneca Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca Business Overview
Table 47. AstraZeneca Gastrointestinal Disorder Therapeutics SWOT Analysis
Table 48. AstraZeneca Recent Developments
Table 49. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Basic Information
Table 50. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Overview
Table 51. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Takeda Pharmaceutical Business Overview
Table 53. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics SWOT Analysis
Table 54. Takeda Pharmaceutical Recent Developments
Table 55. Johnson and Johnson Gastrointestinal Disorder Therapeutics Basic Information
Table 56. Johnson and Johnson Gastrointestinal Disorder Therapeutics Product Overview
Table 57. Johnson and Johnson Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Gastrointestinal Disorder Therapeutics SWOT Analysis
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Recent Developments
Table 61. Eisai Gastrointestinal Disorder Therapeutics Basic Information
Table 62. Eisai Gastrointestinal Disorder Therapeutics Product Overview
Table 63. Eisai Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Eisai Business Overview
Table 65. Eisai Recent Developments
Table 66. Abbott Laboratories Gastrointestinal Disorder Therapeutics Basic Information
Table 67. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Overview
Table 68. Abbott Laboratories Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Recent Developments
Table 71. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Basic Information
Table 72. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Overview
Table 73. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Salix Pharmaceuticals Business Overview
Table 75. Salix Pharmaceuticals Recent Developments
Table 76. Bausch Health Gastrointestinal Disorder Therapeutics Basic Information
Table 77. Bausch Health Gastrointestinal Disorder Therapeutics Product Overview
Table 78. Bausch Health Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Bausch Health Business Overview
Table 80. Bausch Health Recent Developments
Table 81. Allergan Gastrointestinal Disorder Therapeutics Basic Information
Table 82. Allergan Gastrointestinal Disorder Therapeutics Product Overview
Table 83. Allergan Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Allergan Business Overview
Table 85. Allergan Recent Developments
Table 86. Bayer Gastrointestinal Disorder Therapeutics Basic Information
Table 87. Bayer Gastrointestinal Disorder Therapeutics Product Overview
Table 88. Bayer Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Bayer Business Overview
Table 90. Bayer Recent Developments
Table 91. UCB Gastrointestinal Disorder Therapeutics Basic Information
Table 92. UCB Gastrointestinal Disorder Therapeutics Product Overview
Table 93. UCB Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. UCB Business Overview
Table 95. UCB Recent Developments
Table 96. AbbVie Gastrointestinal Disorder Therapeutics Basic Information
Table 97. AbbVie Gastrointestinal Disorder Therapeutics Product Overview
Table 98. AbbVie Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. AbbVie Business Overview
Table 100. AbbVie Recent Developments
Table 101. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Basic Information
Table 102. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Overview
Table 103. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline Recent Developments
Table 106. Astellas Pharma Gastrointestinal Disorder Therapeutics Basic Information
Table 107. Astellas Pharma Gastrointestinal Disorder Therapeutics Product Overview
Table 108. Astellas Pharma Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Astellas Pharma Business Overview
Table 110. Astellas Pharma Recent Developments
Table 111. Global Gastrointestinal Disorder Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Gastrointestinal Disorder Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Gastrointestinal Disorder Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Gastrointestinal Disorder Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Gastrointestinal Disorder Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Gastrointestinal Disorder Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Gastrointestinal Disorder Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Gastrointestinal Disorder Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Gastrointestinal Disorder Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Gastrointestinal Disorder Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Gastrointestinal Disorder Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Gastrointestinal Disorder Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Gastrointestinal Disorder Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Gastrointestinal Disorder Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Disorder Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Disorder Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastrointestinal Disorder Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastrointestinal Disorder Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2022)
Table 10. Global Market Gastrointestinal Disorder Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastrointestinal Disorder Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal Disorder Therapeutics Product Type
Table 13. Global Gastrointestinal Disorder Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal Disorder Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Disorder Therapeutics Market Challenges
Table 22. Global Gastrointestinal Disorder Therapeutics Sales by Type (K Units)
Table 23. Global Gastrointestinal Disorder Therapeutics Market Size by Type (M USD)
Table 24. Global Gastrointestinal Disorder Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Gastrointestinal Disorder Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastrointestinal Disorder Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Gastrointestinal Disorder Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gastrointestinal Disorder Therapeutics Sales (K Units) by Application
Table 30. Global Gastrointestinal Disorder Therapeutics Market Size by Application
Table 31. Global Gastrointestinal Disorder Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Gastrointestinal Disorder Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastrointestinal Disorder Therapeutics Market Share by Application (2019-2024)
Table 35. Global Gastrointestinal Disorder Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastrointestinal Disorder Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Gastrointestinal Disorder Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gastrointestinal Disorder Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gastrointestinal Disorder Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Gastrointestinal Disorder Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gastrointestinal Disorder Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca Gastrointestinal Disorder Therapeutics Basic Information
Table 44. AstraZeneca Gastrointestinal Disorder Therapeutics Product Overview
Table 45. AstraZeneca Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca Business Overview
Table 47. AstraZeneca Gastrointestinal Disorder Therapeutics SWOT Analysis
Table 48. AstraZeneca Recent Developments
Table 49. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Basic Information
Table 50. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Overview
Table 51. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Takeda Pharmaceutical Business Overview
Table 53. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics SWOT Analysis
Table 54. Takeda Pharmaceutical Recent Developments
Table 55. Johnson and Johnson Gastrointestinal Disorder Therapeutics Basic Information
Table 56. Johnson and Johnson Gastrointestinal Disorder Therapeutics Product Overview
Table 57. Johnson and Johnson Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Gastrointestinal Disorder Therapeutics SWOT Analysis
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Recent Developments
Table 61. Eisai Gastrointestinal Disorder Therapeutics Basic Information
Table 62. Eisai Gastrointestinal Disorder Therapeutics Product Overview
Table 63. Eisai Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Eisai Business Overview
Table 65. Eisai Recent Developments
Table 66. Abbott Laboratories Gastrointestinal Disorder Therapeutics Basic Information
Table 67. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Overview
Table 68. Abbott Laboratories Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Recent Developments
Table 71. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Basic Information
Table 72. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Overview
Table 73. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Salix Pharmaceuticals Business Overview
Table 75. Salix Pharmaceuticals Recent Developments
Table 76. Bausch Health Gastrointestinal Disorder Therapeutics Basic Information
Table 77. Bausch Health Gastrointestinal Disorder Therapeutics Product Overview
Table 78. Bausch Health Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Bausch Health Business Overview
Table 80. Bausch Health Recent Developments
Table 81. Allergan Gastrointestinal Disorder Therapeutics Basic Information
Table 82. Allergan Gastrointestinal Disorder Therapeutics Product Overview
Table 83. Allergan Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Allergan Business Overview
Table 85. Allergan Recent Developments
Table 86. Bayer Gastrointestinal Disorder Therapeutics Basic Information
Table 87. Bayer Gastrointestinal Disorder Therapeutics Product Overview
Table 88. Bayer Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Bayer Business Overview
Table 90. Bayer Recent Developments
Table 91. UCB Gastrointestinal Disorder Therapeutics Basic Information
Table 92. UCB Gastrointestinal Disorder Therapeutics Product Overview
Table 93. UCB Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. UCB Business Overview
Table 95. UCB Recent Developments
Table 96. AbbVie Gastrointestinal Disorder Therapeutics Basic Information
Table 97. AbbVie Gastrointestinal Disorder Therapeutics Product Overview
Table 98. AbbVie Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. AbbVie Business Overview
Table 100. AbbVie Recent Developments
Table 101. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Basic Information
Table 102. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Overview
Table 103. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline Recent Developments
Table 106. Astellas Pharma Gastrointestinal Disorder Therapeutics Basic Information
Table 107. Astellas Pharma Gastrointestinal Disorder Therapeutics Product Overview
Table 108. Astellas Pharma Gastrointestinal Disorder Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Astellas Pharma Business Overview
Table 110. Astellas Pharma Recent Developments
Table 111. Global Gastrointestinal Disorder Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Gastrointestinal Disorder Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Gastrointestinal Disorder Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Gastrointestinal Disorder Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Gastrointestinal Disorder Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Gastrointestinal Disorder Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Gastrointestinal Disorder Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Gastrointestinal Disorder Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Gastrointestinal Disorder Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Gastrointestinal Disorder Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Gastrointestinal Disorder Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Gastrointestinal Disorder Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Gastrointestinal Disorder Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Gastrointestinal Disorder Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gastrointestinal Disorder Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Disorder Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Gastrointestinal Disorder Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Gastrointestinal Disorder Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Disorder Therapeutics Market Size by Country (M USD)
Figure 11. Gastrointestinal Disorder Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal Disorder Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal Disorder Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Disorder Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal Disorder Therapeutics Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal Disorder Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Gastrointestinal Disorder Therapeutics by Type in 2023
Figure 20. Market Size Share of Gastrointestinal Disorder Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Gastrointestinal Disorder Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal Disorder Therapeutics Market Share by Application
Figure 24. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal Disorder Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Disorder Therapeutics Market Share by Application in 2023
Figure 28. Global Gastrointestinal Disorder Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gastrointestinal Disorder Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gastrointestinal Disorder Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gastrointestinal Disorder Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gastrointestinal Disorder Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gastrointestinal Disorder Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gastrointestinal Disorder Therapeutics Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gastrointestinal Disorder Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Gastrointestinal Disorder Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gastrointestinal Disorder Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gastrointestinal Disorder Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gastrointestinal Disorder Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastrointestinal Disorder Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastrointestinal Disorder Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastrointestinal Disorder Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Gastrointestinal Disorder Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Gastrointestinal Disorder Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Disorder Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Gastrointestinal Disorder Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Gastrointestinal Disorder Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Disorder Therapeutics Market Size by Country (M USD)
Figure 11. Gastrointestinal Disorder Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal Disorder Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal Disorder Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Disorder Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal Disorder Therapeutics Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal Disorder Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Gastrointestinal Disorder Therapeutics by Type in 2023
Figure 20. Market Size Share of Gastrointestinal Disorder Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Gastrointestinal Disorder Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal Disorder Therapeutics Market Share by Application
Figure 24. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal Disorder Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Disorder Therapeutics Market Share by Application in 2023
Figure 28. Global Gastrointestinal Disorder Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastrointestinal Disorder Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gastrointestinal Disorder Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gastrointestinal Disorder Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gastrointestinal Disorder Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gastrointestinal Disorder Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gastrointestinal Disorder Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gastrointestinal Disorder Therapeutics Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gastrointestinal Disorder Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Gastrointestinal Disorder Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gastrointestinal Disorder Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gastrointestinal Disorder Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gastrointestinal Disorder Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gastrointestinal Disorder Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastrointestinal Disorder Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastrointestinal Disorder Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastrointestinal Disorder Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Gastrointestinal Disorder Therapeutics Market Share Forecast by Application (2025-2030)
